ScRNA-seq of brain metastasis vasculature uncovered CD276-enriched endothelial subtypes with immunoregulatory properties, and CD276 blockade improved survival in preclinical models, suggesting vascular immune checkpoint inhibition as a potential therapeutic strategy across multiple primary tumor types (Bejarano et al., 2024). This evidence concerns the gene CD276 and neoplasm.